Home > Insider Trading > Filing (0001209191-22-025522)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1322505	Albireo Pharma Inc.	ALBO	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1741553	Jason Duncan	C/O Albireo Pharma, Inc. 53 State Street, 19Th Floor Boston MA 02109	Chief Legal Officer And Gc	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2022-04-22	240	$33.07	16,423	No	4	S	Direct
Common Stock	Disposition	2022-04-22	103	$32.93	16,320	No	4	S	Direct
Common Stock	Disposition	2022-04-25	221	$33.44	16,099	No	4	S	Direct
Common Stock	Disposition	2022-04-25	91	$33.40	16,008	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Shares sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
Represents 591 shares of common stock and 15,832 restricted stock units.
Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
Represents 488 shares of common stock and 15,832 restricted stock units.
Represents 579 shares of common stock and 15,520 restricted stock units.
Represents 488 shares of common stock and 15,520 restricted stock units.